dipyridamole has been researched along with Dyskinesia, Medication-Induced in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Chronic administration of haloperidol (1 mg/kg, i." | 1.34 | Protective effect of adenosine reuptake inhibitors in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes. ( Bishnoi, M; Chopra, K; Kulkarni, SK, 2007) |
| "Dipyridamole was administered orally, daily 30 min before IDPN in the doses of 0." | 1.29 | Dipyridamole attenuates the development of iminodipropionitrile-induced dyskinetic abnormalities in rats. ( al-Deeb, S; al-Moutaery, K; Arshaduddin, M; Bruyn, GW; Evans, DA; Tariq, M, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bishnoi, M | 1 |
| Chopra, K | 1 |
| Kulkarni, SK | 1 |
| Tariq, M | 1 |
| al-Deeb, S | 1 |
| al-Moutaery, K | 1 |
| Bruyn, GW | 1 |
| Evans, DA | 1 |
| Arshaduddin, M | 1 |
2 other studies available for dipyridamole and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Protective effect of adenosine reuptake inhibitors in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes.
Topics: Animals; Behavior, Animal; Brain; Catalase; Dipyridamole; Dopamine; Dose-Response Relationship, Drug | 2007 |
Dipyridamole attenuates the development of iminodipropionitrile-induced dyskinetic abnormalities in rats.
Topics: Animals; Behavior, Animal; Brain Chemistry; Chromatography, High Pressure Liquid; Dipyridamole; Dysk | 1995 |